JP2024539156A5 - - Google Patents
Info
- Publication number
- JP2024539156A5 JP2024539156A5 JP2024523661A JP2024523661A JP2024539156A5 JP 2024539156 A5 JP2024539156 A5 JP 2024539156A5 JP 2024523661 A JP2024523661 A JP 2024523661A JP 2024523661 A JP2024523661 A JP 2024523661A JP 2024539156 A5 JP2024539156 A5 JP 2024539156A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- alkyl
- group
- formula
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271097P | 2021-10-22 | 2021-10-22 | |
| US63/271,097 | 2021-10-22 | ||
| PCT/US2022/047438 WO2023069721A2 (en) | 2021-10-22 | 2022-10-21 | Oxazole, oxadiazole, and indole derivatives for the inhibition of usp28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539156A JP2024539156A (ja) | 2024-10-28 |
| JP2024539156A5 true JP2024539156A5 (https=) | 2025-10-22 |
Family
ID=84360746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523661A Pending JP2024539156A (ja) | 2021-10-22 | 2022-10-21 | Usp28阻害のためのオキサゾール、オキサジアゾール、及びインドール誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240425513A1 (https=) |
| EP (1) | EP4419508A2 (https=) |
| JP (1) | JP2024539156A (https=) |
| CN (1) | CN118302414A (https=) |
| WO (1) | WO2023069721A2 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7332508B2 (en) * | 2002-12-18 | 2008-02-19 | Novo Nordisk A/S | Substituted homopiperidine, piperidine or pyrrolidine derivatives |
| PE20151559A1 (es) * | 2013-03-26 | 2015-11-05 | Hoffmann La Roche | Nuevos derivados de piridina |
| GB201603745D0 (en) * | 2016-03-04 | 2016-04-20 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis |
| ES2904615T3 (es) * | 2016-03-16 | 2022-04-05 | Plexxikon Inc | Compuestos y métodos para la modulación de quinasas e indicaciones al respecto |
| CN109666022B (zh) * | 2017-10-17 | 2021-06-15 | 中国科学院上海药物研究所 | 三氮唑衍生物及其制备方法和用途 |
-
2022
- 2022-10-21 EP EP22809277.1A patent/EP4419508A2/en active Pending
- 2022-10-21 WO PCT/US2022/047438 patent/WO2023069721A2/en not_active Ceased
- 2022-10-21 CN CN202280076485.5A patent/CN118302414A/zh active Pending
- 2022-10-21 US US18/703,124 patent/US20240425513A1/en active Pending
- 2022-10-21 JP JP2024523661A patent/JP2024539156A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014222641B2 (en) | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of Hepatitis B | |
| JP6478991B2 (ja) | Ido阻害剤 | |
| JP6505013B2 (ja) | スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用 | |
| JP2023520333A5 (https=) | ||
| JP2011527686A5 (https=) | ||
| JP2010500376A5 (https=) | ||
| US20170362166A1 (en) | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof | |
| JP2023541522A (ja) | 低分子量タンパク質分解物質及びその適用 | |
| JP2009513703A5 (https=) | ||
| JP2009536620A5 (https=) | ||
| US20130096149A1 (en) | Heteroaryl compounds and compositions as protein kinase inhibitors | |
| JP2014528464A5 (https=) | ||
| JP2023531709A5 (https=) | ||
| JP2006501201A5 (https=) | ||
| JP2010527984A5 (https=) | ||
| JP2023531495A5 (https=) | ||
| JP2024509981A5 (https=) | ||
| RU2007116987A (ru) | Новые соединения | |
| BR112020016509A2 (pt) | Composto, composto para uso no tratamento ou profilaxia do câncer de fígado, composição farmacêutica ou medicamento, uso e método para o tratamento ou profilaxia do câncer de fígado | |
| JP2017137323A (ja) | 新規抗がん剤 | |
| RU2011108485A (ru) | Новые (поли)аминоалкиламиноалкиламидные, алкилмочевинные или алкилсульфонамидные производные эпиподофиллотоксина, способ их получения и их применение в терапии в качестве противораковых средств | |
| JP2022517110A5 (https=) | ||
| JP2008500378A5 (https=) | ||
| JP2008519815A5 (https=) | ||
| JP2024539156A5 (https=) |